Original Article

Subject Category: Keratinocytes/Epidermis

Journal of Investigative Dermatology (2007) 127, 2857–2864; doi:10.1038/sj.jid.5700922; published online 28 June 2007

The Activity of Caspase-1 Is Increased in Lesional Psoriatic Epidermis

Claus Johansen1, Kristine Moeller1, Knud Kragballe1 and Lars Iversen1

1Department of Dermatology, Aarhus University Hospital, Aarhus C, Denmark

Correspondence: Dr Claus Johansen, Department of Dermatology, Aarhus University Hospital, P.P. Orumsgade 11, DK-8000 Aarhus C, Denmark. E-mail: claus.johansen@ki.au.dk

Received 4 December 2006; Revised 19 April 2007; Accepted 23 April 2007; Published online 28 June 2007.

Top

Abstract

Caspase-1 belongs to the group of inflammatory caspases and is the activating enzyme for the proinflammatory cytokine IL-18, a cytokine known to play an important role in the pathogenesis of psoriasis. The purpose of this study was to determine the expression of caspase-1 in psoriatic skin and the signaling mechanisms involved in stress-induced activation of caspase-1 and IL-18. Interestingly, increased caspase-1 activity in lesional compared with non-lesional psoriatic skin was seen. In vitro experiments in cultured human keratinocytes demonstrated anisomycin-induced, p38 mitogen-activated protein kinase (p38 MAPK)-dependent increased secretion of procaspase-1 and active caspase-1. Furthermore, anisomycin increased the mRNA expression of IL-18 through a p38 MAPK-dependent but caspase-1-independent mechanism, reaching a maximum level after 12 hours of stimulation. Finally, anisomycin caused a rapid (4 hours) increase in the secretion of proIL-18 and active IL-18. Secretion of active IL-18 was mediated through a p38 MAPK/caspase-1-dependent mechanism, whereas secretion of proIL-18 was mediated by a p38 MAPK-dependent but caspase-1-independent mechanism. These data demonstrate that the activity of caspase-1 is increased in psoriatic skin and that IL-18 secretion is regulated by a p38 MAPK/caspase-1-dependent mechanism, making caspase-1 a potential target in the treatment of psoriasis.

Abbreviations:

LRR, leucine-rich repeat; NACHT, NAip (neuronal apoptosis inhibitory protein), CIITA (MHC class II transcription activator), HET-E (incompatibility locus protein from podospora anserina) and TPI (telomerase-associated protein); PYD, pyrin domain; p38 MAPK, p38 mitogen-activated protein kinase

Extra navigation

.
ADVERTISEMENT